M.D., PhD, FAAN, FEAN, FCAHS

Neurologist. Director of Multiple Sclerosis Centre of Catalonia (Cemcat)

  • Chairman & Director Dept. of Neurology-Neuroimmunology, Vall d’Hebron University Hospital (HUVH)
  • ​Chief of the Neuroimmunology Research Group at the Vall d’Hebron Research Institute (VHIR)
  • Vice-president of the Fundació Esclerosi Múltiple (FEM)
  • President of the Cemcat Foundation
  • Chairman International Medical & Scientific Board of the Multiple Sclerosis International Federation
  • Scientific Committee & Board Member of the European Charcot Foundation
  • Former President of the European of the Committee for Treatment and Research in Multiple Sclerosis
  • Member of the International Panel on Multiple Sclerosis Diagnostic Criteria
  • Neuroscience Topic Advisory Group ICD11 of World Health Organization
  • Professor of Neurology and Neuroimmunology Chair Director of the Faculty of Medicine, Universitat Autònoma de Barcelona
  • Co-editor/Editor for Clinical Cases, Multiple Sclerosis Journal
  • Multiple Sclerosis Area Director of Revista de Neurología
     

Previous positions:

Vicepresident of the Sociedad Española de Neurología (SEN), 2014-2016
Member of the Steering Committee of Magnetic Resonance Imaging in MS (MAGNIMS), 1997-2014
Member of Scientific Commitee of European School of Neuroimmunology (ESNI), 1999-2013

Education

MD and PhD in Neuroimmunology, Universitat Autònoma de Barcelona
Postdoctoral fellowship at the Lupus Research Institute
Clinical training National Hospital for Neurology and Neurosurgery, Queen Square in London (UK)
MBA Esade Business School


Career

2012-2016            Chairman and Director Dept. of Neurology-Neuroimmunology, Vall d’Hebron University Hospital (HUVH)
2007-2016            Director of Multiple Sclerosis Centre of Catalonia (Cemcat)
2006-2016            Professor of Neurology, Universitat Autònoma de Barcelona
2010-2012            Clinical director of Neuroscience, HUVH
2005-2010            Clinical Head, Neurology Department, HUVH
1990-2012            Director, Clinical Neuroimmunology Unit, HUVH


Projects / Lines of Research / Interests

Prof. Montalban has been in the inception phases and on steering committees of many clinical trials as an expert and key opinion leader in Multiple Sclerosis. He has authored over 400 original and revision publications in International peer-reviewed journals as well as several book chapters.

As a chief of the Neuroimmunology Research Group at the Vall d’Hebron Research Institute (VHIR), he is also working on MR imaging and biological prognostic factors of disease evolution and treatment response, immunological mechanisms of the disease and other aspects of clinical management of MS. Of note in Medicine education is the UAB postgraduate online Master's Degree in Neuroimmunology offered to physicians with some experience in the field.

His research interests include clinical aspects of MS: he has directed the development of the first Spanish (second worldwide) Multiple Sclerosis Clinical Practice Guidelines. He also has led the European Guidelines for Treatment of MS, of which Prof. R. Gold is co-chair.


Bio

Dr. Xavier Montalban is chair of the Department of Neurology-Neuroimmunology and director of the Multiple Sclerosis Centre of Catalonia at Vall d’Hebron University Hospital in Barcelona, as well as the chief of the Neuroimmunology Research Group at Vall d’Hebron Research Institute. From July 2017 to May 2020, he has been Professor of Medicine, the Director of the Division of Neurology at the University of Toronto and Director of the MS Centre at St Michael’s Hospital.

Dr. Montalban received his medical license, trained as a neurology specialist and completed his PhD in neuroimmunology at the Universitat Autònoma de Barcelona. He went on to undertake a postdoctoral fellowship at the Lupus Research Institute, Guy’s & St. Thomas’ Hospital with additional clinical training at the National Hospital for Neurology and Neurosurgery, Queen Square in London, United Kingdom.

Dr. Montalban is the President of the Cemcat Foundation and former President and current Honorary Member of the Council of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). He is the Vice Chair of the NMSS/Ectrims Clinical Trials Committee and has been the Chair of the Medical & Scientific Board of the Multiple Sclerosis International Federation (MSIF). He is a Board member of the European Charcot Foundation and of the international initiative PROMS.

For the past twenty-five years, Dr. Montalban has been in the inception phases and on steering committees of many clinical trials related to multiple sclerosis. He has authored over 500 original and revision publications in international peer-reviewed journals plus several book chapters. He has been editor for the Clinical Cases Section of the Multiple Sclerosis Journal. Recently, he co-directed the development of the first ECTRIMS-EAN Multiple Sclerosis Treatment Guidelines. 

His research interests include clinical trials, clinical aspects of MS, MR imaging and biological prognostic factors of disease evolution and treatment response, immunological mechanisms of the disease and other aspects of clinical management of MS. He has been exposed to a vast variety of neurological diseases in both sides of the Atlantic.


Honours and Career Awards

Distinctions and Research Awards

INTERNATIONAL
Received

2021*

 
Tribute to individuals whose passion, talent and expertise make the greatest contributions to LACTRIMS in their professional career. Latin American Committee for Treatment and Research in Multiple Sclerosis (LACTRIMS). *Award ceremony Nov 2020 postponed due to COVID-19.
 
2020
 
2020 Highly Cited Researchers from the Web of Science Group
 
2019
 
2019 Highly Cited Researchers from the Web of Science Group
 
2018
 
2018 Highly Cited Researchers from the Web of Science Group
 
2017
 
Honorary Member of the Council, European Committee for Treatment and Research in Multiple Sclerosis. (ECTRIMS)
 

 

NATIONAL
Received

2018

 
Award Best in Class (BIC 2018) to the Best Service in Multiple Sclerosis, Gaceta Médica y Cátedra de Innovación y Gestión Sanitaria de la Universidad Rey Juan Carlos. (Distinction)
 
2018
 
2018 Spanish doctor ambassadors (only 20 elected out of all Spanish physicians), Diario Médico. (Distinction)
 
2016

 
“Agustí Codina Puiggròs” to the best article in Neurology, Societat Catalana de Neurologia. (Distinction)
 
2014

 
Award Best in Class (BIC 2014) to the Best Service in Multiple Sclerosis, Gaceta Médica y Cátedra de Innovación y Gestión Sanitaria de la Universidad Rey Juan Carlos. (Distinction)
 
2009
 
Award of Multiple Sclerosis, modalidad Científica, Sociedad Española de Neurología. (Distinction)